CA9 and head and neck cancer: Peridis et al. [23] conducted random-effect meta-analytical techniques to evaluate the prognosis of head and neck cancer with CAIX expression from sixteen studies and found that the presence of CAIX in head and neck malignant tumors was associated with reduced overall survival and disease-free survival.